Armis Biopharma, founded with a mission to improve societal health by protecting humans, animals, and the environment from harmful pathogens, specializes in developing non-systemic drugs. Their core product, Veriox® Technology, is a potent antimicrobial and anti-toxin platform based on a proprietary peracid/hydrogen peroxide formulation. This technology offers a highly selective action against a wide range of bacterial and viral pathogens, verified by both government and private laboratories.
Notable figures associated with Armis Biopharma include experts in biopharmaceutical development and key investors committed to advancing healthcare innovations. The company's significant achievements include the successful independent verification of Veriox® Technology's efficacy, positioning it as a leading solution in pathogen elimination. Armis Biopharma's impact lies in its innovative approach to non-systemic treatments, contributing to enhanced public health and safety.
